Where is Topaz Pharmaceuticals's headquarters?
Topaz Pharmaceuticals's headquarters is located at 100 Witmer Road, Horsham.
What is Topaz Pharmaceuticals's latest funding round?
Topaz Pharmaceuticals's latest funding round is Acquired.
How much did Topaz Pharmaceuticals raise?
Topaz Pharmaceuticals raised a total of $20.5M.
Who are the investors of Topaz Pharmaceuticals?
Investors of Topaz Pharmaceuticals include Sanofi Pasteur, Aisling Capital, F-Prime Capital, Ben Franklin Technology Partners of Southeastern PA and Fidelity Investments.
Who are Topaz Pharmaceuticals's competitors?
Competitors of Topaz Pharmaceuticals include Aquinox Pharmaceuticals, Provepep, Conatus Pharmaceuticals, MAP Pharmaceuticals, Micromet and 11 more.
You May Also Like
EctoPharma is a company developing therapeutic pesticides for specific healthcare and veterinary markets, for conditions such as the treatment of human head lice.
IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.
Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a specific class of GPCRs known to be relevant in a variety of disease states.
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.
Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.
P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.